野村:下調中人壽(2628.HK)目標價至20.24港元 去年業績符合預期
野村發表研究報告指,中國人壽(2628.HK)去年業績符合預期,認為去年中人壽加大了發展力度,新業務價值按年升18.6%,跑嬴同業,但指出隨着中國政府推出一系列經濟寬鬆政策,低息環境將會中人壽帶來挑戰,下調目標價至20.24港元,維持“買入”投資評級。
野村預期中人壽今年新業務價值按年升8%,繼續跑羸同業,惟自2017年起中人壽對新業務價值的投資回報不斷上升,但政府債券的殖利率卻不斷下降,情況未見樂觀。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.